QLQ-CAX24 Phase4

Projekt

QLQ-CAX24 Phase4

Automatisch geschlossen · 2017 bis 2017

Strasser Florian, Domeisen Benedetti Franzisca, Attoun-Knobel Suzanne

Art

Klinische Forschung

Reichweite

Multizentrisch, KSSG als teilnehmendes Zentrum

Bereiche

Zentrum für Integrative Medizin, Palliativzentrum, Medizinische Onkologie und Hämatologie

Status

Automatisch geschlossen

Start

2017

Ende

2017

Finanzierungsart

Andere

Studiendesign

The primary study objective is to test the scale structure, reliability, responsiveness to change and validity of the EORTC QLQ-CAX24 in conjunction with the EORTC QLQ-C30 in people diagnosed with cancer cachexia with different primary cancer diagnoses, at different stages of disease, and with different amount of secondary nutrition impact symptoms.

Kurzbeschreibung/Zielsetzung

The aim of the present study is to test the scale structure, reliability, responsiveness to change and validity of the EORTC QLQ-CAX24 in conjunction with the EORTC QLQ-C30 in people diagnosed with cancer cachexia with different primary cancer diagnoses, at different stages of disease, and with different amount of secondary nutrition impact symptoms (S-NIS). N=240-360 patients with cachexia syndrome (Group A), n=240-360 patients with refractory cachexia (Group B) and n=50 patients with weight loss <2% (Group C) will be recruited.